(Q34157378)

31 July 2017

1 reference

title

Cannabidiol: an overview of some pharmacological aspects (English)

1 reference

31 July 2017

0 references

0 references

1 reference

1

Raphael Mechoulam

1 reference

31 July 2017

3

Ruth Gallily

1 reference

31 July 2017

Linda A Parker

2

1 reference

31 July 2017

1 November 2002

1 reference

The Journal of Clinical Pharmacology

31 July 2017

1 reference

31 July 2017

42

1 reference

31 July 2017

11S-19S

1 reference

31 July 2017

11 Suppl

1 reference

Letter: Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents.

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Interaction of Δ9-tetrahydrocannabinol and cannabidiol with phenobarbitone in protecting mice from electrically induced convulsions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Cannabidiol and phenytoin: a structural comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Brain cannabinoid systems as targets for the therapy of neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Anticonvulsant effects of the (-) and (+)isomers of cannabidiol and their dimethylheptyl homologs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Sedative activity of cannabis in relation to its delta'-trans-tetrahydrocannabinol and cannabidiol content

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Antianxiety effect of cannabidiol in the elevated plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Biphasic effects of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Hypnoticlike effects of cannabidiol in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Reduced binocular depth inversion in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Different effects of nabilone and cannabidiol on binocular depth inversion in Man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Nitric oxide and macrophage function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Cannabinoid receptors and immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Neuropharmacology of emesis induced by anti-cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Neuronal responses to delta 9-tetrahydrocannabinol in the solitary tract nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Area postrema mediates the formation of rapid, conditioned palatability shifts in lithium-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Rewarding drugs produce taste avoidance, but not taste aversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

The taste reactivity test. I. Mimetic responses to gustatory stimuli in neurologically normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Behavioral conditioned responses across multiple conditioning/testing trials elicited by lithium- and amphetamine-paired flavors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Rotation-induced conditioned rejection in the taste reactivity test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Chin rub CRs may reflect conditioned sickness elicited by a lithium-paired sucrose solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Area postrema mediation of physiological and behavioral effects of lithium chloride in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Absence of lithium-induced taste aversion after area postrema lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Effects of antiemetics on the acquisition and recall of radiation- and lithium chloride-induced conditioned taste aversions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Toxin-induced conditioned changes in taste reactivity and the role of the chemosensitive area postrema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

CB(1) receptor antagonist SR141716A inhibits Ca(2+)-induced relaxation in CB(1) receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.2002.TB05998.X

10.1002/J.1552-4604.2002.TB05998.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12412831